Genomics Market (Genechips, Reagents for DNA Extraction & Purification, Sequencing) Worth $19.0 Billion by 2018 - New Report by MarketsandMarkets

The global genomics instrument and consumables segments were further categorized into nucleic acid extraction and purification systems, PCR, DNA microarrays, DNA sequencers, and NGS platforms. http://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketsandMarkets

MarketsandMarkets

Leading Players - Roche Diagnostic (Switzerland), Life Technologies, Corp. (U.S.), QIAGEN (Netherlands), Illumina, Inc. (U.S.)

(PRWEB) April 08, 2014

New analysis from MarketsandMarkets "Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018" finds that the Global Genomics Market earned revenues of $11.11 billion in 2013 and estimates this market to reach over $19.0 billion by 2018.

Browse 49 market data tables and 52 figures spread through 248 pages and in-depth TOC on “Genomics Market"
http://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html

Early buyers will receive 10% customization on this report.

The report segments the Global Genomics market by products (instrument, consumables, and services), by technology (Nucleic acid extraction & purification, PCR, DNA sequencing, and DNA microarray), by application (diagnostics, personalized medicine, academic research, agriculture & animal health, and academic research), and by geography (North America, Europe, APAC, and RoW). Technological advancements (Nanopore sequencing, customized microarray, and d-PCR), increasing capital investment by public and private capitalists in genetic researches, as well as innovations in bioinformatics tools for advanced application in drug discovery and academic research are considered the key drivers for the global genomics market.

Ask for Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=613.

“The future of genomics lies in the personalized medicine industry. Government initiatives and considerable investments are expected to drive genetic research on personalized medicines that utilize base pairs of the human genome sequence”.

As of now, the application of personalized medicine is primarily focused on drug discovery for oncology, vaccine production, as well as infectious disease-therapeutic areas. The usage and application areas for genomic research in personalized medicine are expected to increase significantly in coming years.

Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=613.

Over the last decade, Tier I and Tier II companies were found to be dominant in the instruments and consumables product segments of the genomics market. Moreover, increasing market consolidation through consecutive restructuring activities by leading players has proved to be a challenge for new entrants. “Market penetration in the genomics services sub-segment would be a suitable strategy for start-ups. Increasing dependency of small and medium scale research institutes on outsourced services is expected to drive the market significantly,” concludes Antan. “Partnering with Tier I and Tier II manufacturers reduces the initial capital investment, and allows small scale service providers to leverage established brand names for market penetration.”

Leading market players in this market include Roche Diagnostic (Switzerland), Life Technologies, Corp. (U.S.), QIAGEN (Netherlands), Illumina, Inc. (U.S.), and Bio-Rad Laboratories, Inc. (U.S.).

The Global Genomics Market study is part of the Biotechnology subscription title, which also includes research in the following markets: Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to 2017, and Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Trends & Global Forecasts to 2017.

Browse Related Reports:
Global DNA and Gene Chip (Microarrays) Market (2010 – 2015)
http://www.marketsandmarkets.com/Market-Reports/genechips-367.html

Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to 2017
http://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology.
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets.


Contact

Follow us on: Contact's Google Plus